Articles tagged with Granulocytes
Researchers discovered that stress hormones trigger neutrophils to detach from blood vessel walls and travel to the heart, causing inflammation. Blocking these stress signals with beta blockers may prevent excessive inflammation and improve heart healing.
Researchers investigate the role of mast cells in eosinophilic esophagitis, a chronic disease causing inflammation and scarring. The study aims to identify new treatments to improve quality of life for patients with EoE.
Researchers from Tokyo Medical and Dental University have identified a previously unknown intermediate cell type, pre-basophils, which plays a critical role in the differentiation of precursor cells into mature basophils. These newly discovered cells exhibit higher proliferation capacity and distinct surface protein expression profiles...
Scientists from USC Stem Cell laboratory discovered a mechanism linking leukemic mutations to varying disease potentials, identifying RNA splicing regulator Rbm25 as a critical factor. The study found that over-contributing clones of blood stem cells produce excessive myeloid cells, leading to potential leukemia development.
A new study from Karolinska Institutet in Sweden found that COVID-19 disease severity is linked to the characteristics of white blood cells called granulocytes. Combined measurements of granulocyte characteristics and widely used biomarkers can predict key clinical features such as respiratory function and multiorgan failure.
A study found that G-CSF stimulates the production of macrophages and reduces inflammation, suggesting its role in regulating adaptive immunity. The factor may also participate in recovery processes, opening up new possibilities for treating leukopenia and inflammatory diseases.
A study confirms mitochondrial deficits in children with autism, which affect the functioning of granulocytes and lead to increased oxidative stress. The findings suggest that deficiencies in energy metabolism may contribute to cognitive impairments associated with autism.
Scientists discovered microRNA-223, which controls the production and activation of granulocytes in the innate immune response. Absence of microRNA-223 increased tissue inflammation and damage.